Virbac SA
Update in progressVIRP.PA (Paris)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - General
Virbac SA develops, manufactures, and markets veterinary medicines and related products for companion and farm animals worldwide. The portfolio includes vaccines, antibiotics, parasiticides, anti-inflammatories, dermatology, dental, nutrition, diagnostics, pet food, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. Founded in 1968, it is headquartered in Carros, France.
Company score
- Sentiment
- 0.46
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.06
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.24
- Governance
- 0.07
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.10
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.28
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketParis (PAR)
- LocationFrance
- CEOMr. Habib Ramdani
- Founded1968
- Employees6,442
- Websitecorporate.virbac.com
Identifiers
- ISINFR0000031577
- LEI969500QQ1X5XHG649644